Wednesday, July 8, 2026

biotech · Hematological or solid tumor malignancies or autoimmune diseases · Intracerebral Haemorrhage · IPSC

Century Therapeutics

News and analysis for Century Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Philadelphia, USA HQ
2018 Founded
104 Employees
Public company Type
IPSC · NYSE Ticker
Company details
Status
Public
HQ
Philadelphia, USA
Founded
2018
Employees
104
Programs
10
Drugs
9
Patents
39
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Century Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Century Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Century Therapeutics yet.

Back to company overview →